Invivyd (IVVD) Other Accumulated Expenses (2022 - 2026)
Invivyd's (IVVD) quarterly Other Accumulated Expenses came in at $52000.0 in Q4 2025, up 92.59% YoY from $27000.0 in Q4 2024, and up 62.5% on a QoQ basis from $32000.0 in Q3 2025.
Invivyd (IVVD) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
Invivyd (IVVD) has 4 years of Other Accumulated Expenses data on file, last reported at $52000.0 in Q4 2025.
- Quarterly Other Accumulated Expenses rose 92.59% year-over-year to $52000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52000.0 (up 92.59% YoY) and the FY2025 annual result came in at $52000.0, up 92.59% from the prior year.
- Other Accumulated Expenses improved to $52000.0 in Q4 2025, from $32000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $58000.0 in Q2 2022 to a low of $20000.0 in Q3 2024.
- A 4-year average of $37666.7 and a median of $35000.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses slumped 49.06% — and 2025, when it surged 92.59%.
- Tracing IVVD's Other Accumulated Expenses over 4 years: stood at $44000.0 in 2022, then fell by 20.45% to $35000.0 in 2023, then slipped by 22.86% to $27000.0 in 2024, then surged by 92.59% to $52000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $52000.0 (Q4 2025), $32000.0 (Q3 2025), and $26000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Invivyd | 212.23 Mn | 52.15 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 58,000.00 |